FibroBiologics to Present at Advanced Wound Care Summit USA
FibroBiologics will be represented by Chief Scientific Officer,
Details of the presentations are as follows:
Oral Presentation:
Presentation Title: Fibroblast Spheroid-mediated Accelerated Chronic Wound Healing in a Diabetic Mouse Model
Presenter:
Session Title: Research and Development - Biologics
Session Date and Time: April 16, 2024, at
Poster Presentation:
Presentation Title:
Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model
Presenter: Subhiksha Raghuram, MS, MD, Associate Scientist, FibroBiologics
Poster Session: Available Virtually
"The data we will present highlights the clinical potential of fibroblast cell-based treatment for chronic wounds such as diabetic foot ulcers and venous ulcers," said
For more information, please visit FibroBiologics' website or email FibroBiologics at: info@fibrobiologics.com.
Cautionary Statement Regarding Forward-Looking Statements
This communication contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning the potential of fibroblast cell therapies to treat chronic wounds such as diabetic foot ulcers, and venous ulcers, and the potential of such treatments to revolutionize wound care by harnessing the specific capacity of fibroblasts in wound healing. These forward-looking statements are based on FibroBiologics' management's current expectations, estimates, projections and beliefs, as well as a number of assumptions concerning future events. When used in this communication, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside FibroBiologics' management's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements, including those set forth under the caption "Risk Factors" and elsewhere in FibroBiologics' annual, quarterly and current reports (i.e., Form 10-K, Form 10-Q and Form 8-K) as filed or furnished with the
About FibroBiologics
Based in
Investor Relations:
(646) 942-5599
fibrobiologicsIR@russopr.com
Media Contact:
(347) 956-7697
Elizabeth.phillips@russopartnersllc.com
General Inquiries:
info@fibrobiologics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/fibrobiologics-to-present-at-advanced-wound-care-summit-usa-302087502.html
SOURCE FibroBiologics